No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 18. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.
| Company | Type | Value | Reported | Company | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICER | Option exercise | nothing paid30,000 shares | Sep 3, 2026 | Mirum Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICER | nothing paid | Option exercise | 30,000 | Sep 3, 2026 |
| Mirum Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICER | Open-market sell | $2,145,16021,688 shares | Sep 3, 2026 | Mirum Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICER | $2,145,160 | Open-market sell | 21,688 | Sep 3, 2026 |
| Mirum Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICER | Open-market sell | $815,2418,312 shares | Sep 3, 2026 | Mirum Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICER | $815,241 | Open-market sell | 8,312 | Sep 3, 2026 |
| Mirum Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICER | Option exercise | $88,08030,000 shares | Sep 3, 2026 | Mirum Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICER | $88,080 | Option exercise | 30,000 | Sep 3, 2026 |
| Mirum Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICER | Option exercise | nothing paid20,000 shares | Aug 11, 2026 | Mirum Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICER | nothing paid | Option exercise | 20,000 | Aug 11, 2026 |